TOAGF yields 4.71% · JNJ yields 2.13%● Live data
📍 TOAGF pulled ahead of the other in Year 1
Combined, TOAGF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOAGF + JNJ for your $10,000?
Toagosei Co., Ltd., together with its subsidiaries, manufactures, distributes, and sells chemical products in Japan and internationally. The company operates through Commodity Chemicals, Polymer & Oligomer, Adhesive Material, Performance Chemicals, and Plastics segment. It offers inorganic products, including liquid caustic soda, liquid chlorine, synthetic hydrochloric acid, sodium hypochlorite, caustic and super potash, sulfuric acid, sodium sulfite, potassium pyrophosphate, and copper oxide, as well as iron perchloride, hypochiorous acid, copper pyrophosphate, and copper potassium pyrophosphate solutions; chlorinated solvents, such as trichlorethylene and tetrachlorethylene; and ammonium sulfate and potassium bicarbonate fertilizers. The company also provides acrylic monomers; acrylamide tertiary butyl sulfonic acid and ethylene carbonate; acrylic polymers, such as dispersants, thickeners, scale inhibitors, pressure sensitive adhesives, binders, paint vehicles, and gelling agents; special polymers; solvent-free acrylic polymers; special acrylic monomers; polymer flocculants; and UV-curable resins. Further, the company provides instant glues and functional adhesives; inorganic chemicals, such as liquid hydrogen chloride, and hexachlorodisilane, as well as potassium hydroxide and carbonate aqueous, and ferric chloride solutions; and inorganic functional materials, including electronic materials and amenity care materials. Additionally, it offers industrial gases, such as oxygen, nitrogen, argon, hydrogen, carbon dioxide, and mixed gas; and products for the construction and civil engineering. The company was founded in 1933 and is headquartered in Tokyo, Japan.
Full TOAGF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.